MXPA04000647A - Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas. - Google Patents

Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.

Info

Publication number
MXPA04000647A
MXPA04000647A MXPA04000647A MXPA04000647A MXPA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A MX PA04000647 A MXPA04000647 A MX PA04000647A
Authority
MX
Mexico
Prior art keywords
aminolevulinic acid
ulcers
phtosensitizer
photochemotherapy
esters
Prior art date
Application number
MXPA04000647A
Other languages
English (en)
Spanish (es)
Inventor
Klaveness Jo
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of MXPA04000647A publication Critical patent/MXPA04000647A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA04000647A 2001-07-26 2002-07-25 Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas. MXPA04000647A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118251.8A GB0118251D0 (en) 2001-07-26 2001-07-26 Method
PCT/GB2002/003386 WO2003011265A2 (en) 2001-07-26 2002-07-25 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds

Publications (1)

Publication Number Publication Date
MXPA04000647A true MXPA04000647A (es) 2004-05-17

Family

ID=9919248

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000647A MXPA04000647A (es) 2001-07-26 2002-07-25 Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.

Country Status (13)

Country Link
US (1) US20040259949A1 (cg-RX-API-DMAC7.html)
EP (1) EP1414430A2 (cg-RX-API-DMAC7.html)
JP (1) JP2005501050A (cg-RX-API-DMAC7.html)
KR (1) KR20040030863A (cg-RX-API-DMAC7.html)
CN (1) CN1533271A (cg-RX-API-DMAC7.html)
CA (1) CA2454136A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ2004257A3 (cg-RX-API-DMAC7.html)
GB (1) GB0118251D0 (cg-RX-API-DMAC7.html)
HU (1) HUP0401192A3 (cg-RX-API-DMAC7.html)
MX (1) MXPA04000647A (cg-RX-API-DMAC7.html)
NO (1) NO20040321L (cg-RX-API-DMAC7.html)
RU (1) RU2004105655A (cg-RX-API-DMAC7.html)
WO (1) WO2003011265A2 (cg-RX-API-DMAC7.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
NL1020336C2 (nl) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Toepassing van een verbinding voor de bereiding van een farmaceutisch preparaat voor het behandelen van brandwonden, en een werkwijze voor het behandelen van brandwonden.
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
WO2004085416A1 (en) * 2003-03-24 2004-10-07 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0420888D0 (en) * 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
JP2010502595A (ja) * 2006-08-29 2010-01-28 スティッチング ヴォア デ テクニシェ ウェテンシャッペン 真菌性皮膚疾患の治療用医薬組成物及びその製造方法
AU2008337067A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
CA2906990A1 (en) * 2008-04-04 2009-10-08 Duke University Non-invasive systems and methods for in-situ photobiomodulation
RU2395315C1 (ru) * 2008-12-01 2010-07-27 Государственное унитарное предприятие г. Москвы Международный научный и клинический центр "Интермедбиофизхим" (ГУП МНКЦ "Интермедбиофизхим") Способ фотодинамической терапии гнойных ран и трофических язв
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
SI2440199T1 (sl) 2009-06-11 2016-05-31 Photocure Asa Poltrdni sestavki in farmacevtski proizvodi
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
WO2011107478A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
US20130211215A1 (en) 2010-06-23 2013-08-15 Photocure Asa Hyperosmotic preparations comprising 5-aminolevulinic acid or derivative as photosensitizing agent
CA2804337A1 (en) 2010-07-09 2012-01-12 Photocure Asa Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
WO2012012616A1 (en) * 2010-07-21 2012-01-26 Patty-Fu Giles Photoactive vitamin nanoparticles for the treatment of chronic wounds
WO2012076985A2 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
EP2657346B1 (en) 2010-12-24 2017-08-23 ARKRAY, Inc. Method for detecting cancer cell
KR101254758B1 (ko) * 2011-02-28 2013-04-15 부산대학교병원 광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
KR101254752B1 (ko) * 2011-02-28 2013-04-15 부산대학교 산학협력단 광역동치료의 광증감제로 사용하기 위한 구연산을 이용한 아미노레불리닉산 트라이머
EP2722041B1 (en) * 2011-06-16 2018-10-24 SBI Pharmaceuticals Co., Ltd. Therapeutic agent for allergic rhinitis
EP2766049A1 (en) 2011-10-14 2014-08-20 Photocure ASA Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
EP2794004B1 (en) 2011-12-19 2020-07-29 Photocure ASA Irradiation apparatus
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス,インコーポレイテッド 創傷充填デバイスおよび方法
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
DK3011972T3 (da) * 2013-06-19 2019-11-04 Sbi Pharmaceuticals Co Ltd Medicinsk sammensætning til fremme af syntese af protoporphyrin IX
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
RU2604399C1 (ru) * 2015-12-01 2016-12-10 Сергей Владимирович Москвин Способ лазерной терапии больных трофическими язвами
RU2661084C1 (ru) * 2017-07-21 2018-07-11 Федеральное Агентство Научных Организаций Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ комплексного лечения пролежней у пациентов с длительной иммобилизацией
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CN112062713B (zh) * 2020-08-04 2023-03-31 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds

Also Published As

Publication number Publication date
KR20040030863A (ko) 2004-04-09
US20040259949A1 (en) 2004-12-23
JP2005501050A (ja) 2005-01-13
CZ2004257A3 (cs) 2004-08-18
WO2003011265A2 (en) 2003-02-13
NO20040321L (no) 2004-03-19
WO2003011265A3 (en) 2003-04-24
HUP0401192A3 (en) 2005-07-28
CN1533271A (zh) 2004-09-29
RU2004105655A (ru) 2005-04-10
CA2454136A1 (en) 2003-02-13
GB0118251D0 (en) 2001-09-19
HUP0401192A2 (hu) 2004-12-28
EP1414430A2 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
MXPA04000647A (es) Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.
WO2002064163A3 (en) Reduction or prevention of pdt related inflammation
EP1649853A3 (en) Microtubule stabilizing agents for treating atherosclerosis or restenosis
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
NO20060307L (no) Anvendelse av kinoazolinderivatet ZD6474 kombinert med platinaforbindelser og eventuelt ioniserende straling i behandling av sykdommer assosoiert med angiogenese og/eller okt vaskulaert permeabilitet
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
PT784429E (pt) Combinacoes terapeuticas de dilatadores venosos e dilatadores arteriais
EP1251126A3 (en) Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
DK0396184T3 (da) Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
DE602007008385D1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
NO20000446D0 (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser
WO2001024783A3 (de) Verwendung von (+)-tramadol, o-demethyltramadol bzw. (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol bzw. (+)-o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
IS8186A (is) Meðferð fyrir uppskurð á verkjum eftir uppskurð
RU2460555C1 (ru) Способ лечения ожоговых ран
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
DE60126199D1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
DE60232154D1 (de) Prophylaktische und therapeutische verwendung von hydroxysteroiden
EP1270000A3 (en) Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
BR0111546A (pt) Produto combinado, método para a produção de um kit de partes, kit de partes, método de tratamento de uma condição, usos de um produto combinado ou de um kit de partes, e, de um melagatrano e de um inibidor de fator viia, ou de um derivado farmaceuticamente aceitável dos mesmos